We are live on ! Find out more
ARMC

American Research & Management Company Portfolio holdings

AUM $362M
1-Year Est. Return 8.06%
This Fund
S&P 500
This Quarter Est. Return
+4.04%
1 Year Est. Return
-8.06%
3 Year Est. Return
+35.06%
5 Year Est. Return
+60.88%
10 Year Est. Return
–
AUM
$260M
AUM Growth
+$22M
Cap. Flow
+$12.7M
Cap. Flow %
4.88%
Top 10 Hldgs %
34.67%
Holding
391
New
8
Increased
34
Reduced
90
Closed
22

Top Buys

Rank Stock Value
1
IBM icon
IBM
IBM
+$943K
2
ADBE icon
Adobe
ADBE
+$778K
3
CELG
Celgene Corp
CELG
+$554K
4
BIIB icon
Biogen
BIIB
+$498K
5
IMO icon
Imperial Oil
IMO
+$400K

Top Sells

Rank Stock Value
1
PRAA icon
PRA Group
PRAA
+$738K
2
DE icon
Deere & Co
DE
+$477K
3
RBS.PRG
RBS CAPITAL FUNDING TRUST VII GTD TR PFD SEC 6.08%
RBS.PRG
+$442K
4
JNJ icon
Johnson & Johnson
JNJ
+$306K
5
CHD icon
Church & Dwight Co
CHD
+$274K

Sector Composition

Rank Sector Weight
1 Technology 17.95%
2 Miscellaneous 17.52%
3 Healthcare 15.33%
4 Consumer Staples 14.14%
5 Energy 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PSK icon
51
State Street SPDR ICE Preferred Securities ETF
PSK
$678M
$1.3M 0.5%
28,325
-3,500
-11% -$159K
NVO
52
Novo Nordisk
NVO
$202B
$1.24M 0.48%
46,000
-3,100
-6% -$85K
RTX icon
53
RTX Corp
RTX
$285B
$1.18M 0.45%
18,275
+3,712
+25% +$238K
VNO.PRG.CL
54
DELISTED
Vornado Realty Trust
VNO.PRG.CL
$1.16M 0.44%
44,125
-900
-2% -$23.3K
OXY icon
55
Occidental Petroleum
OXY
$59.1B
$1.08M 0.42%
14,290
-220
-2% -$16.4K
GILD icon
56
Gilead Sciences
GILD
$181B
$1.07M 0.41%
12,865
+4,100
+47% +$364K
MSFT icon
57
Microsoft
MSFT
$3.81T
$1.05M 0.41%
20,593
-398
-2% -$20.7K
PFE icon
58
Pfizer
PFE
$159B
$1.01M 0.39%
30,106
-2,486
-8% -$79.3K
AMGN icon
59
Amgen
AMGN
$234B
$874K 0.34%
5,744
-135
-2% -$21K
VRTX icon
60
Vertex Pharmaceuticals
VRTX
$137B
$843K 0.32%
9,800
+200
+2% +$17.3K
EMLC icon
61
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$835K 0.32%
22,125
– –
MMP
62
DELISTED
Magellan Midstream Partners, L.P.
MMP
$827K 0.32%
10,888
-500
-4% -$35.5K
BNY
63
Bank of New York Mellon
BNY
$110B
$760K 0.29%
19,556
– –
MAR icon
64
Marriott International
MAR
$91.5B
$755K 0.29%
11,359
-500
-4% -$33.5K
BPFHP
65
DELISTED
Boston Private Financial Holdings, Inc.
BPFHP
$709K 0.27%
27,283
+2,208
+9% +$57K
HP icon
66
Helmerich & Payne
HP
$4.25B
$692K 0.27%
10,315
– –
EMB icon
67
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$15B
$682K 0.26%
5,920
-200
-3% -$22.3K
GOOG icon
68
Alphabet (Google) Class C
GOOG
$4.19T
$602K 0.23%
17,300
-1,220
-7% -$43.8K
MSM icon
69
MSC Industrial Direct
MSM
$6.66B
$558K 0.21%
7,910
-375
-5% -$27.8K
WELL icon
70
Welltower
WELL
$172B
$529K 0.2%
6,946
-100
-1% -$7.1K
VZ icon
71
Verizon
VZ
$208B
$527K 0.2%
9,436
-700
-7% -$36.3K
KMI icon
72
Kinder Morgan
KMI
$70.3B
$519K 0.2%
27,725
+800
+3% +$14.3K
DE icon
73
Deere & Co
DE
$170B
$502K 0.19%
6,200
-5,823
-48% -$477K
RDS.B
74
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
$453K 0.17%
8,095
-300
-4% -$15.4K
BP icon
75
BP
BP
$109B
$434K 0.17%
14,525
-627
-4% -$16.9K
1 2
3
4 5

Similar funds

BPM
Bowling Portfolio Management Cincinnati, Ohio $364M AUM 7.07% 1-Year Est. Return
S
Surevest Los Angeles, California $368M AUM 13.7% 1-Year Est. Return
ACM
Axar Capital Management New York $304M AUM 38.78% 1-Year Est. Return
GMA
Goldstein Munger & Associates San Ramon, California $303M AUM 19.66% 1-Year Est. Return
AW
ACG Wealth Atlanta, Georgia $437M AUM 11.28% 1-Year Est. Return
RFA
Radnor Financial Advisors Wayne, Pennsylvania $284M AUM 23.21% 1-Year Est. Return
AIA
AGF Investments America Toronto, Ontario, Canada $271M AUM 7.04% 1-Year Est. Return
SMG
Spectrum Management Group Indianapolis, Indiana $460M AUM 10.37% 1-Year Est. Return

American Research & Management Company's Q2 2016 Portfolio in Review

As of Q2 2016, American Research & Management Company held 391 positions worth $260M, up 9.3% from $238M the previous quarter. Its ten largest holdings account for 35% of the portfolio.

American Research & Management Company deployed $12.7M of net new capital in Q2 2016, opening 8 new positions and adding to 34 existing holdings. Its largest new stake was Edwards Lifesciences: 3,900 shares worth $130K.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Miscellaneous and Healthcare.

On the sell side, the largest reduction was PRA Group, an estimated $738K trimmed.

  • American Research & Management Company's largest Q2 2016 buy was Edwards Lifesciences: 3,900 shares worth $130K.
  • American Research & Management Company added most to IBM in Q2 2016, an estimated $943K increase.
  • American Research & Management Company's biggest Q2 2016 reduction was PRA Group, cutting an estimated $738K.
  • American Research & Management Company fully exited RBS CAPITAL FUNDING TRUST VII GTD TR PFD SEC 6.08% in Q2 2016, selling an estimated $442K.
  • American Research & Management Company's ten largest holdings make up 35% of its $260M portfolio in Q2 2016.
  • American Research & Management Company opened 8 new positions and closed 22 in Q2 2016.
  • American Research & Management Company's portfolio value rose 9.3% quarter-over-quarter to $260M.

Based on American Research & Management Company's 13F filing for Q2 2016, filed 29 Jul 2016.